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While  extensive  studies  in  humans  have  documented the  biological  and 
immunological properties of transfer factor in vivo,  it is apparent that an in 
vitro assay system is required for further biochemical purification and charac- 
terization, as well as for analysis of its mechanism of action (1,  2).  The term 
transfer factor (TF) ~  was originally introduced to designate those components in 
leukocyte extracts responsible for the in vivo transfer of delayed-type hypersen- 
sitivity in man (3). The term is a  convenient operational description and not a 
biochemical entity, and it is employed with the appreciation that more than one 
factor may be involved in the effects observed. It is understood that dialysates of 
leukocytes are complex mixtures of small molecules which in addition to immu- 
nologically specific components of TF, also contain other low molecular weight 
materials  with  potential  biological  activity.  An  assessment  of the  relative 
contributions of such specific and nonspecific components to the in vivo and in 
vitro activities of leukocyte dialysates is an obligatory prelude to further purifi- 
cation and characterization of TF and to the design of a  meaningful in vitro 
assay of its activity. 
We have recently described preliminary studies assessing lymphocyte blasto- 
genesis  as  a  potential  assay  for  TF  activity  (4,  5).  In  this  system  it  was 
demonstrated  (5)  that  when  prepared  in  tissue  culture  medium,  leukocyte 
dialysates containing TF augmented antigen-triggered proliferation of human 
lymphocytes in vitro. Preliminary experiments designed to assess the immuno- 
logical specificity and underlying mechanism(s) of the phenomenon were also 
reported. These observations have been subsequently confirmed and extended to 
show that the augmentation caused by antigen in  the presence of leukocyte 
dialysate  was  greater  on  those  recipient  lymphocytes which  had  a  higher 
baseline proliferative response to antigen alone (6-9). 
* This work was supported in part by U. S. Public Health Service grant AI-01254, U. S. Public 
Health Service  Training Grant AI-00005-17, and the Medical  Scientist Training Program NIH 
Grant 5 TO5-GM01668. 
1Abbreviations  used  in  this  paper:  Ag,  antigen; [~4C]TdR, ~4C-labeled thymidine; D.Tox., 
diptheria toxoid; Acpm, the arithmetic difference in cpm between cultures containing  antigen plus 
leukocyte dialysate and cultures containing just antigen;  [3H]TdR; tritiated thymidine; LF, 
flocculation unit; ln, natural log; MEMS, minimal essential media for suspension cultures; PPD, 
purified protein derivative of tuberculin; SK-SD, streptokinase-streptodornase; TF, transfer fac- 
tor; TU, tuberculin units. 
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To facilitate the analysis of the action of leukocyte dialysate we have devel- 
oped a microculture adaptation of the macrosystem reported earlier  (5).  With 
this technique it has become possible to apply multiple dialysates to the recipi- 
ent lymphocytes of a single individual and conversely to assay a single dialysate 
preparation on the lymphocytes of multiple recipients.  This adaptation facili- 
tates the determination of the relative  contributions of the dialysate  and cul- 
tured lymphocytes to the augmentation observed. 
In this report we present detailed evidence to show that the augmentation of 
lymphocyte proliferation produced by leukocyte dialysates plus antigen: (a) does 
not occur when precommitted, antigen-specific lymphocytes are deleted from the 
recipient population by the "hot-pulse" technique of Dutton and Mishell  (10); 
and (b)  appears to be due mainly to a nonspecific adjuvant effect of leukocyte 
dialysates, the magnitude of which is determined by the immune reactivity of 
recipient lymphocytes, rather than that of the leukocyte dialysate donor. 
Materials and Methods 
Selection of Donors and Recipients of Leukocyte Dialysates.  All donors were  normal  adult 
human volunteers with a normal leukocyte and differential count at the time of venipuncture. The 
donors for dialysate preparations as well as those employed for recipient leukocyte cultures were 
selected to  cover  a  broad  spectrum  of delayed  cutaneous  reactivity  from  complete  absence of 
reactivity to exquisite hypersensitivity to the antigens under study.  Skin tests were performed 
with  purified  protein  derivative  of tuberculin  (PPD):  5  tuberculin  units  (TU)  or  250  TU;  or 
diphtheria toxoid (D.Tox.): 0.008 fiocculation unit (Lf). Skin tests of 10 mm or more induration at 
48 h were considered positive. In addition to delayed cutaneous reactivity in vivo, the responses of 
prospective donors  and recipients of dialysate  were  also  assessed by a  microadaptation of the 
lymphocyte transformation test (11). 
Preparation of Leukocyte Dialysates.  Each  10 ml of venous blood were mixed with 1.0 ml of 
preservative-free, sodium heparin (Schwarz/Mann Div., Beton, Dickinson & Co., Orangeburg, N. 
Y.; 100,000  U/g, 2 mg/ml) and 1.0 ml of 6% dextran (Sigma Chemical Co., St. Louis, Mo.; average 
mol wt, 250,000) in saline, and the erythrocytes were allowed to sediment for a half hour at 37°C in 
glass tubes (16  ×  125 mm). The leukocyte-rich plasma was removed and total and differential cell 
counts were performed. This plasma was centrifuged at 300 g  for 15 min at 5°C. The cell pellet was 
then suspended  in  1  ml  of sterile  double-distilled water  and immediately frozen in a  dry-ice- 
acetone bath. These frozen pellets were stored at -20°C or below. Pancreatic DNase I (Worthing- 
ton Biochemical Corp.,  Freehold,  N.  J.;  twice recrystallized),  0.1  mg,  was added to the lysate 
which was then subjected to 10 cycles of freezing and thawing between a dry-ice-acetone bath and a 
25°C water bath. The lysate was then dialyzed against minimal essential media used for suspen- 
sion cultures (MEMS) (Microbiological Associates,  Bethesda, Md.). The dialysis tubing (Arthur 
H.  Thomas Co.,  Philadelphia, Pa.;  1/4 inch diameter,  0.002 inch wall thickness, initial average 
pore size 48 A) was washed twice and boiled twice in sterile pyrogen-free H20 or saline.  The 
dialysate volume was adjusted to yield a  leukocyte extract of 1.0 ×  107 mononuclear cell equiva- 
lents/ml of dialysate.  After an overnight dialysis,  the dialysate was  filtered  (Millipore Corp., 
Bedford, Mass.; Millex filter, 0.45~tm) and stored at 4°C until use. The temperature and pH were 
adjusted before the addition of experimental leukocyte suspensions by placing the dialysate in a 
37°C 5% CO2 incubator. 
Deletion of Clones of Antigen-Reactive  Cells with  [3H]Thymidine  of High  Specific Activ- 
ity.  Venous blood  was  sedimented  at  37°C  for  a  half hour  with  heparin  and  dextran  as  for 
dialysate preparations.  A  differential count was performed  and the leukocyte-rich plasma  was 
centrifuged at 300 g  for 15 min at room temperature.  The cell pellet was resuspended in MEMS 
supplemented with 1% 200 mM  glutamine (Microbiological  Associates)  and 50 ~g/ml gentamicin 
(Schering Diagnostics Div., Schering Corp.,  Port Reading, N. J.) while the supernatant plasma 
was clarified  by centrifugation  at 900  g for 20 min. 
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established in glass culture tubes  (16  x  125 ram) containing 1.0  ×  10  e mononuclear cells/ml of 
media with 15% autologous plasma. Antigens were added to duplicate or triplicate cultures at the 
following concentrations: PPD(Connaught Laboratories, Toronto, Canada; PPD-CT 68, preserva- 
tive free, lot A-11)  ~ 2.5 ~g/ml; D.Tox.  (Massachusetts Public Health Biologic Laboratory, Boston, 
Mass.; preservative free)  3 8.25 Lf/ml; or streptekinase-streptodornase (SK-SD) (Lederle Laborato- 
ries,  Pearl  River,  N.  Y.;  Varidase,  dialyzed to remove preservative) 50 SK and  12.5 SD U/ml. 
Antigen  concentrations  were  chosen  to  stimulate  responsive  cells  optimally.  These  antigen- 
stimulated cultures and parallel cultures without antigen were incubated at 37°C in a humidified 
5% CO2 incubator. At 24 and again at 48 h  both test and control cultures received 2.5 ~tCi/ml of 
tritiated thymidine [3H]TdR (New England Nuclear, Boston, Mass.; sp act, 20 Ci/mmol) to inhibit 
proliferating cells. 
At 72 h the extracellular [3H]TdR was removed by two washes with MEMS, 5 ml each. Replicate 
tubes were pooled and the cells resuspended at approximately 1.5  x  l0  s mononuclear cells/ml in 
MEMS supplemented with 30% autologous plasma and double the above concentrations of gluta- 
mine and gentamicin. 
Microtechnique for Leukocyte Culture with Antigen and Leukocyte Dialysate.  The cell popula- 
tion thus prepared and depleted of cells responding by proliferation to a specific antigen were then 
cultured with both the specific and unrelated antigens using a  microtechnique. Each group was 
assayed in triplicate for [~4C]thymidine incorporation. 
0.1 ml of the [3H]TdR pulsed cell suspensions were added to an equal volume of either ME MS or 
leukocyte  dialysate  in sterile round-bottomed microplates  (Linbro Chemical  Co.,  New  Haven, 
Conn.; no. IS-MRC-96TC).  To these secondary cultures PPD, D.Tox., or SK-SD was added atthe 
same concentrations as had been used in the primary cultures. Blastogenesis in cultures without 
additional antigen was also measured. 
Microcultures were incubated at 37°C in a humidified 5% COs incubator. 6 days later thymidine 
incorporation  was  measured  by  the  addition  of 0.03  ~Ci  of  [~4C]thymidine  ([~4C]TdR)  (New 
England Nuclear; sp act, approximately 50 ~Ci/mmol) to each well. Distilled water lysates or TCA 
precipitates were harvested 8-10 h later on glass fiber filters and counted in a liquid scintillation 
counter  (Beckman  Instruments,  Inc.,  Fullerton,  Calif.;  LS  150)  equipped  with  an  automatic 
quench  control,  which  minimized  any  3H  spillover  into  the  ~4C  window.  This  machine  also 
compensated for quenching, allowing all samples to be counted at a constant efficiency. All results 
are therefore reported as counts per minute of [~4C]TdR incorporated during the last 8-10 h  of 
culture. 
Analysis  of Data.  Data were studied in the form of raw counts per minute, natural log (ln) 
counts per minute, and stimulation ratios (as described in the Results). Use of the In counts per 
minute normalized the error (13) and was therefore used to perform statistical analyses. Analyses 
of variance,  regression,  and  covariance  were  performed  on  a  PDP-8  computer  according  to 
standard methods (14). 
Results 
Spectrum  of Donor  Reactivity.  The  lymphocytes of the  individuals  who 
served as donors for these experiments covered a  broad range of reactivity in 
vitro for the three antigens employed. As shown in Table I, stimulation ratios 
(counts per minute with antigen/counts per minute without antigen) ranged 
from 1 to 102 for PPD, 1 to 22 for D.Tox., and 1 to 47 for SK-SD. The group of six 
individuals that served as donors of dialysate and the eight individuals whose 
lymphocytes served as recipients,  each covered a  comparable broad range of 
reactivity. Stimulation ratios of 9 or greater corresponded to at least  10  mm 
induration with PPD or D.Tox. 
Lack  of Mitogenic  Effect  by  Leukocyte  Dialysates  on  Unstimulated  Cul- 
tures.  In this microsystem the addition of dialysate alone did not stimulate 
2 Generous gift of Dr.  S. Landy. 
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TABLE  I 
In Vitro Reactivity of the Donors of Leukocyte Dialysates and Recipient Lymphocyte 
Cultures 
cpm Thymidine incorporation 
No anti- 
PPD  D.Tox.  SK-SD  gen 
A. Dialysate donors 
HuC  34  2,346  (69.0)*  40  (1.2)  634  (18.6) 
W.S.  18  1,839 (102.2)  77  (4.3)  240  (13.3) 
V.L.  122  116  (0.9)  76  (0.6)  126  (1.0) 
B.S.  17  825  (48.5)  306  (18.0)  338  (19.9) 
R.R.  74  3,222  (43.5)  1,613  (21.8)  1,856 (25.1) 
C.M.  87  113  (1.3)  290  (3.3)  111  (1.3) 
B. Recipient lymphocyte cultures 
B.A.  31  99  (3.2)  -  235 (7.6) 
J.C.  51  3,264  (64.0)  -  2,372  (46.5) 
W.S.  42  2,466  (58.7)  145  (3.5)  266  (6.3) 
F.V.  36  39  (1.1)  468  (13.0)  236 (6.6) 
D.  V.P.  52  483  (9.3)  54  (1.0)  171  (3.3) 
A.S.  23  i,678  (73.0)  47  (2.0)  37  (1.6) 
J. Ca.  33  27  (0.8)  32  (1.0)  259  (7.8) 
L.G.  65  836  (12.9)  303  (4.7)  186  (2.9) 
* Geometric mean of the cpm of |~4C]TdR incorporated in triplicate cultures. Numbers in paren- 
theses are stimulation ratios (cpm with antigen divided by cpm without antigen). 
normal  lymphocytes.  In  eight  consecutive experiments,  the  triplicate  sets  of 
cultures in the absence of antigen had a geometric mean of 37 cpm (range 23-65). 
In the presence of dialysate alone, these sets had a  geometric mean of 34 cpm 
(range 21-94), a difference that is not statistically significant.  Moreover, dialy- 
sate from sensitive donors did not behave as an antigen in cultures of leukocytes 
obtained from donors with exquisite cutaneous reactivity to the same antigen. 
These cultures are capable of response to nanogram quantities of antigen (15). 
Augmenting  Effect  of Leukocyte  Dialysates  on  Antigen-Stimulated  Cul- 
tures.  Dialysates usually enhanced the incorporation of thymidine by antigen- 
stimulated lymphocytes. Pooling all data from nonsensitive and sensitive indi- 
viduals, in 46 different combinations of dialysate and recipient cells, the mean 
thymidine incorporation was increased 2.23  _+ 0.26 SE-fold over that seen with 
antigen (Ag) alone in cultures without specific clonal deletions. 4 Fig. 1 shows the 
cumulative  frequency  distribution  of the  augmentation  ratios  (cpm  [Ag  + 
dialysate]/cpm[Ag]). The median ratio was only 1.3 and in approximately one- 
third of the trials the ratio was less than one. The augmentation ratio remained 
constant with increasing reactivity of the recipient cells to antigen alone (corre- 
lation coefficient, 0.04).  However, as we had initially observed [see Table I in 
Ascher  et  al.  (5)],  the  arithmetic  difference  between the  counts  per  minute 
incorporated  by antigen-stimulated  lymphocytes in  culture  with  and  without 
4 One of nine dialysates, prepared for these studies, was toxic and has not been included in the 
data because it consistently  and nonspecifically  depressed the background level of  response of  cells 
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dialysate (Acpm) increased with increasing reactivity of the recipient cells (Fig. 
2). Ascher and Andron (6), and Hamblin and colleagues (7, 9) have subsequently 
published similar results in this system. 
Comparison of Leukocyte Dialysates from Skin-Test Positive with those from 
Negative  Donors.  Mean  augmentation  ratios,  as  defined  in  the  preceding 
section were 2.32  (range  0.4-6.5)  with dialysate  from skin-test-positive  donors 
and  2.09  (range  0.5-5.6)  with  dialysate  from skin-test-negative  donors.  Thus, 
dialysate  from  positive  and  negative  donors  produced  similar  augmentation 
ratios,  which did not differ statistically. 
In order to compare Acpm from positive and negative donors, it was necessary 
to correct for the  differing reactivity  of the  various  recipient cells  to antigen 
alone. Regression lines were calculated separately for dialysates of positive and 
negative  donors  using  the  In  counts  per  minute  obtained  in  the  presence  of 
dialysates  and  antigen  (ordinate)  vs.  the In counts per minute obtained with 
antigen  alone  (abscissa).  The slopes and y  intercepts for the lines of sensitive 
and nonsensitive  donors were compared in an analysis of covariance. 
A  separate  analysis  was  performed  for each  antigen,  comparing  dialysate 
preparations obtained from positive and from negative donors. Using this data, 
dialysates  from sensitive  and  nonsensitive  donors  could  not be distinguished 
from each other.  Similarly,  when the results obtained with positive dialysates 
for all three antigens  were pooled and compared to all negative  dialysates  the 
two regression lines thus obtained did not differ significantly from each other in 
either slope or y  intercept. Fig. 3 is a scattergram of the counts per minute with 
antigen  in  the  presence  or  absence  of dialysates  from  positive  and  negative 
donors. 
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FIG. 2.  hcpm(cpm[dialysate  + Ag] -  cpm[Ag  alone]) plotted against the cpm of [14C]TdR 
incorporated into leukocytes  cultured in the presence of antigen. Each point represents 
triplicate cultures. Closed circles represent dialysate from nonsensitive donors and open 
circles from sensitive donors. 
culture system by assaying three different dialysates simultaneously on cells 
from three different recipients. An analysis of  variance showed that the intrinsic 
level of lymphocyte reactivity was the major source of variation in the thymi- 
dine  incorporation  by  such  cells  in  the  presence  of dialysate.  In  fact,  the 
component of variance due  to  the  different dialysates was  one-sixth that of 
experimental error while the component due to different recipient cells was four 
times greater than experimental error. The data from this experiment is sum- 
marized in Table II. 
As shown in Table I, donor C. M.'s in vitro reactivities to the three antigens 
are markedly less than that of the other two donors. Donor C. M. was skin-test 
negative to 250 TU of tuberculin. Nevertheless, her dialysate augmented lym- 
phocyte proliferation to tuberculin, as well as did the dialysates of  the two more 
positive donors (B. S. and R. R.). This emphasizes again that the augmentation 
seen in these experiments is not a function of the dialysate donor's responsive- 
ness to antigen. 
Effect of Depletion of Antigen-Responsive  Cells on Augmentation by Leuko- 
cyte Dialysate  Preparations.  Cell  populations  were  specificially depleted of 
either PPD-,  D.Tox.- or,  SK-SD-responsive cells by triggering them with the 
respective antigen in the presence of lethal doses of [~H]TdR. A representative 
experiment is shown in Tables II-V. Control cell populations were cultured with 
[3H]TdR but no antigen as shown in Table II. Aliquots of lymphocyte popula- 
tions treated in this fashion were then cultured subsequently with or without COHEN,  HOLZMAN~  VALENTINE~  AND  LAWRENCE  797 
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not significantly different from each other. 
antigen and in the presence or absence of dialysate as shown in Tables III-V. 
The stimulation  ratio  (cpm with  Ag/cpm  without Ag)  in undepleted popula- 
tions that were  cultured without dialysate  was  used as a  measure  of "control" 
stimulation.  This ratio was also calculated for undepleted populations cultured 
with dialysate and then expressed as a percentage of the control. Percentages  of 
greater than 100 indicate augmentation over antigen alone by dialysate.  Stimu- 
lation  ratios  were  calculated  for  populations  that  were  depleted  of antigen- 
reactive  cells  and  then  cultured  with  antigen  and  with  or without dialysate. 
These ratios were expressed as a percentage of the undepleted control.  Percent- 
ages  of  less  than  100  indicate  reduced  antigen-triggered  proliferation  after 
clonal  deletion,  regardless  of the  presence  or  absence  of dialysate.  Table  VI 
summarizes  the  percentages  obtained  when  lymphocytes  were  cultured  both 
with  and  without  dialysates,  and  includes  experiments  using  eight  dialysate 
preparations obtained from six donors and cultured with the cells of eight other 
individuals. 
In control cultures, in the absence of dialysate, as seen on the left side of Table 
VI, the suicide technique significantly reduced the proliferative response to the 
specific antigen used with lethal thymidine but not to unrelated antigens.  Thus, 798  LEUKOCYTE  DIALYSATES  ENGAGE  PRECOMMITTED  CELLS 
TABLE  II 
CPM* and Stimulation Ratios$ Obtained when Three Different Leukocyte Dialysates 
were Simultaneously Assayed on Three Different Recipient Populations of  Lymphocytes § 
Lymphocyte  Dialysate  No anti- 
PPD  D.Tox.  SK-SD  recipient  donor  gen 
J. Ca.  None  33  27 (0.8)  32 (1.0)  259  (7.8) 
R.R.  29  28 (1.0)  38 (1.3)  485 (16.7) 
B.S.  28  25 (0.9)  41  (1.5)  402  (14.4) 
C.M.  27  27 (1.0)  47  (1.7)  693  (25.7) 
A. S, 
D. V. P. 
None  23  1,678  (73.0)  47  (2.0)  37  (1.6) 
R.R.  25  6,959 (278.4)  135 (5.4)  240 (9.6) 
B.S.  26  6,990 (268.8)  271  (10.4)  232 (8.9) 
C.M.  21  6,928 (329.9)  175 (8.3)  203  (9.7) 
None  52  483  (9.3)  54 (1.0)  171 (3.3) 
R.R.  35  166 (4.7)  53  (1.5)  59 (1.7) 
B.S.  30  2,058 (68.6)  73  (2.4)  208  (6.9) 
C.M.  45  2,693 (59.8)  66 (1.5)  332  (7.4) 
* Geometric means of triplicate cultures. 
* cpm with antigen divided by cpm without antigen. 
§ The coefficient of variation for the data in this set of experiments (Tables II, III, IV, and V) is 
8.3%. 
lymphocytes from individuals  sensitive  to more than  one antigen,  responded 
normally to unrelated antigens whose clones were not deleted by this technique. 
In the presence of dialysate the proliferation of cells in response to the specific 
antigen was similarly impaired (right side of Table VI), whereas augmentation 
by dialysate of the responses to unrelated antigens was not affected. 
For example, as is shown in Table VI, the population of cells that had been 
previously incubated  with  D.Tox.  in  the  presence of lethal  thymidine,  when 
placed in secondary culture with D.Tox. plus dialysate responded at a  level of 
63% of control while the response of the same cells to SK-SD was 219% of control. 
Conversely,  when  the  SK-SD-responsive cells were depleted,  the  response  of 
these cells to subsequent culture with SK-SD and dialysate was 46% of control 
(SK-SD  without  dialysate),  while  the  same  cells,  cultured  with  D.Tox.  and 
dialysate  had  a  stimulation  ratio  37%  of the  control  value  (D.Tox.  without 
dialysate). Thus, in reciprocal experiments, dialysate enhanced only the ongo- 
ing proliferation induced by antigen. 
It should be noted that the boxed percentages in Table VI suggest that clonal 
deletion may have been incomplete. This impression is not correct and results 
from an  artifact  produced by averaging  the  data  obtained from subjects who 
were nonreactive to the antigen (and hence had little or no change after the hot 
pulse) and those who had strong reactivity (whose responses were abrogated by 
thymidine  suicide).  When  clonal  deletions  were not  complete,  dialysate  pro- 
duced a residual augmentation in the responsive cells that remained. Thus, de 
novo  sensitization was not observed in this in vitro system. 
Discussion 
Our original observations using a macrosystem of lymphocyte culture to study 
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TABLE  III 
CPM and Stimulation Ratios ~  Obtained when Three Different Leukocyte Dialysates were 
Simultaneously Assayed on Three Different Recipient Populations of Lymphocytes from 
which the PPD-Responsive Cells had been Deleted§ 
Lymphocyte  Dialysate  No anti-  PPD  D.Tox.  SK-SD 
recipient  donor  gen 
J. Ca. 
A. S. 
D.  V. P. 
None  41  28 (0.7)  29 (0.7)  345 (8.4) 
R.R.  30  24 (0.8)  80 (2.7)  517  (17.2) 
B.S.  27  26 (1.0)  88 (3.3)  539  (20.0) 
C.M.  28  24 (0.9)  52 (1.9)  688  (24.6) 
None  564  807 (1.4)  476(0.8)  242  (0.4) 
R.R.  520  1,323  (2.5)  393  (0.8)  413  (0.8) 
B.S.  633  1,372  (2.2)  800  (1.3)  342 (0.5) 
C.M.  710  1,886 (2.7)  644 (0.9)  346  (0.5) 
None  129  158 (1.2)  182 (1.4)  462 (3.6) 
R.R.  209  1,748  (8.4)  339 (1.6)  626 (3.0) 
B.S.  65  853  (13.1)  164 (2.5)  1,138 (17.5) 
C.M.  105  652 (6.2)  309 (2.9)  798  (7.6) 
* Geometric means 
$ cpm with antigen 
§ The coefficient of 
8.3%. 
of triplicate cultures. 
divided by cpm without antigen. 
variation for the data in this set of experiments (Table II, III, IV, and V) is 
detailed evidence for the antigen dependence of the phenomenon and suggestive 
evidence of its  concordance with  the  cutaneous reactivity of the  donor  (5). 
Palmer and Smith (16), Arala-Chaves et al.  (17), and Basten et al.  (18) have 
reported results that also suggest a role for the cutaneous reactivity of the donor 
in contributing to the results observed. In each of these reports it was empha- 
sized that antigen specificity had not been established and that more detailed 
studies to evaluate the possible contribution of nonspecific adjuvant effects of 
crude leukocyte dialysates were required. 
In the  experiments reported here, the  magnitude of the  augmentation of 
antigen-stimulated lymphocyte proliferation, as measured by hcpm, occurring 
in the presence of dialysate was found to be a function of the underlying native 
reactivity of the recipient's lymphocytes to antigen rather than determined by 
the  immune reactivity of the  dialysate donor.  When  the  differences in  the 
baseline reactivity to antigen of  the recipient's cells were adjusted by analysis of 
covariance, the augmentation effects of dialysates from sensitive and nonsensi- 
tive donors were identical. In contrast to  hcpm, the augmentation ratio was 
found to be independent of the native reactivity of the recipient lymphocytes. 
Similar augmentation ratios were seen with dialysates from positive and nega- 
tive donors.  These results confirm and extend similar observations reported 
independently by Hamblin and co-workers (7, 9). In addition, we have observed 
that the dialysate by itself  is not mitogenic and did not behave as an antigen in a 
lymphocyte  culture system capable of detecting nanogram quantities of antigen 
(15). 
The data provides evidence that,  at least in this in vitro blood lymphocyte 
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TABLE  IV 
CPM* and Stimulation Ratios$ Obtained when Three Different  Leukocyte Dialysates 
were Simultaneously Assayed on Three Different Recipient Populations of Lymphocytes 
from which the D.Tox.-Responsive Cells had been Deleted§ 
Lymphocyte  Dialysate  No anti-  PPD  D.Tox.  SK-SD  recipient  donor  gen 
J.  Ca. 
A. S. 
D. V. P. 
None  85  56 (0.7)  50 (0.6)  432 (5.1) 
R.R.  67  80 (1.2)  59 (0.9)  1,344 (20.1) 
B.S.  167  103 (0.6)  70 (0.4)  1,196 (7.2) 
C.M.  122  98 (0.8)  77 (0.6)  1,047 (8.6) 
None  24  1,725 (71.9)  24 (1.0)  33 (1.4) 
R.R.  30  3,623 (120.8)  61 (2.0)  40 (1.3) 
B.S.  29  4,837 (166.8)  31 (1.1)  129 (4.4) 
C.M.  26  4,708 (181.1)  50 (1.9)  127 (4.9) 
None  24  381 (15.9)  39 (1.6)  73 (3.0) 
R.R.  38  2,088 (54.9)  30 (0.8)  35 (0.9) 
B.S.  40  3,408 (85.2)  41 (1.0)  443 (11.1) 
C.M.  30  3,644 (121.5)  42 (1.4)  564 (18.8) 
* Geometric means of triplicate cultures. 
* cpm with antigen divided by cpm without antigen. 
§ The coefficient of variation for the data in this set of experiments  (Tables II, III, IV, and V) is 
8.3%.  J 
antigen  only  of precommitted  lymphocyte  populations,  and  do  not  initiate 
antigen reactivity in uncommitted cells. This interpretation is suggested by the 
observed increase  in  Acpm  produced  by  addition  of leukocyte dialysate  plus 
antigen which parallels the level of the baseline reactivity of recipient lympho- 
cytes to antigen alone. If, for example, a fixed number of uncommitted lympho- 
cytes were engaged by materials in the dialysate, then the hcpm should remain 
constant and the ratio of counts per minute in the presence of dialysate plus 
antigen divided by counts per minute in the presence of antigen alone, should 
decrease as levels of baseline reactivity of recipient cells increased. In fact Acpm 
increased and the ratio remained unchanged. This finding is consistent with the 
interpretation that the dialysate exerts its effect only on lymphocytes that are 
already reacting to antigen, i.e., precommitted cells. 
Direct  evidence for this  conclusion  is  provided by the  demonstration  that 
dialysates were unable to initiate or augment responses to a  given antigen in 
populations of cells that had been previously depleted of lymphocytes capable of 
responding to that particular antigen.  Taken together these data support the 
conclusion that the augmentation observed in this system arises from nonspe- 
cific adjuvant effects present in leukocyte dialysate prepared from nonimmune 
as well as immune individuals. 
Leukocyte dialysates  are  known  to  contain  a  mixture  of small  molecules 
which may act to augment or to inhibit lymphocyte proliferation. A  number of 
substances  such  as  serotonin,  ascorbic  acid,  and  an  unidentified  cholinergic 
agent have been detected recently in such dialysates and shown to elevate cyclic 
GMP levels in human  monocytes  (19),  and  it is possible that the nonspecific 
effect of dialysate may be mediated via the monocyte. Increases in cyclic GMP COHEN,  HOLZMAN,  VALENTINE,  AND  LAWRENCE  801 
TABLE V 
CPM* and Stimulation Ratios~ Obtained  when Three Different Leukocyte Dialysates 
were Simultaneously Assayed on Three Different Recipient Populations of Lymphocytes 
from which the SK-SD-Responsive  Cells had been Deleted§ 
Lymphocyte  Dialysate  No anti- 
PPD  D.Tox.  SK-SD  recipient  donor  gen 
J. Ca. 
A. S. 
D. V. P. 
None  71  76 (1.1)  149 (2.1)  149 (2.1) 
R.R.  144  70 (0.5)  327 (2.3)  330 (2.3) 
B.S.  76  78 (1.0)  418 (5.5)  455 (6.0) 
C.M.  58  60 (1.0)  244 (4.2)  329 (5.7) 
None  24  2,117 (88.2)  69 (2.9)  24 (1.0) 
R.R.  30  5,876 (195.9)  154 (5.1)  24 (0.8) 
B.S.  28  5,159 (184.3)  551 (19.7)  38 (1.4) 
C.M.  24  4,809 (200.4)  407 (17.0)  26 (1.1) 
None  69  436 (6.3)  64 (0.9)  38 (0.6) 
R.R.  37  3,418 (92.4)  -  - 
B.S.  81  4,518 (55.8)  84 (1.0)  93 (1.1) 
C.M.  36  3,457 (96.0)  115 (3.2)  110 (3.1) 
* Geometric means of triplicate cultures. 
$ cpm with antigen divided by cpm without antigen. 
§ The coefficient of variation for the data in this set of experiments (Tables II, III, IV, and V) is 
8.3%. 
TABLE VI 
Failure of Leukocyte Dialysates to Restore the Response of Lymphocyte Populations 
Depleted of Antigen-Reactive  Cells 
Secondary antigen without dialy-  Secondary antigen with dialysates 
Antigen  sates 
clone deleted 
PPD  D.Tox.  SK-SD  PPD  D.Tox.  SK-SD 
None  100"  100  100  279 ± 58  221 ± 38  254 ± 50 
PPD  33 ±  14  75 ±  16  82 ± 20  49 ±  13  152 ± 32  132 ± 39 
D.Tox.  95 ±  17  58 ± 21  98 ± 25  316 ±  100  63 ±  10  219 ± 45 
SK-SD  87 ±  15  106 ± 25  26 ± 6  294 ± 84  370 ± 90  46 ± 8 
* Percent of control stimulation ratio; each number represents the mean of 6 to 16 experiments ± 
the SE. Boxed percentages are significantly less than 100%. 
levels  in  lymphocytes,  however,  have  been  shown  to  result  in  proliferation 
which is antagonized by cyclic AMP (20-22). In addition, dialysates may contain 
a mixture of other small molecules (i.e. histamine, oligonucleotides, cold thymi- 
dine,  calcium  ions,  etc.)  which  may  act  to  augment  or  inhibit lymphocyte 
proliferation or  [14C]TdR incorporation. The preponderance of one or another 
substance such as serotonin or histamine, in leukocyte dialysates will vary from 
preparation  to  preparation  even  from  the  same  dialysate  donor.  This  may 
account for the observation that a  particular leukocyte dialysate may in some 
instances inhibit lymphocyte proliferation. The incorporation of ['4C]TdR which 
occurs in the presence of dialysate probably reflects the summation of the effects 
of these  agents,  superimposed on the  underlying reactivity of the  recipients' 
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Other attempts to develop an in vitro assay for TF activity using leukocyte 
dialysates haVe been reported in which lymphokine production is  measured. 
These include the adaptation of the leukocyte capillary migration technique of 
S~berg and Bendixen (23) which depends on the production of leukocyte inhibi- 
tory factor. Zabriskie and colleagues (24, 25) using leukocyte dialysates contain- 
ing TF have reported on the conversion of nonimmune blood leukocyte popula- 
tions to immune reactivity as measured by inhibition of leukocyte migration in 
the presence of tuberculin (PPD) or measles virus antigen. Similar results have 
been reported subsequently by Brandes and Goldenberg (26) using leukocyte 
dialysates from E-B virus-positive donors to confer inhibition of migration upon 
nonreactive cells in the presence of nasopharyngeal carcinoma antigens. How- 
ever, the establishment of the immunological specificity of these in vitro effects 
of dialysates will also require more extensive study. 
An in vitro assay for TF based on lymphocyte  blastogenesis remains attractive 
because it would reflect the in vivo observation that after the administration of 
TF, the recipient's lymphocytes respond to antigen by proliferation as well as by 
lymphokine production. While the studies reported here highlight the capacity 
of the  lymphocyte blastogenesis  assay to  selectively reveal the  nonspecific, 
adjuvant activities of the materials present in crude leukocyte dialysates, it 
would be premature to conclude that the system cannot be refined to study the 
antigen-specific activities of TF. Basten et al. (18) have recently presented data 
to show that crude dialysates after purification by gel filtration yield a fraction 
which when assayed on recipient lymphocytes of weak intrinsic reactivity only 
causes augmentation of proliferation in the presence of the antigen to which the 
dialysate donor is reactive and not in the presence of antigen to which he is 
unreactive. If these preliminary findings are confirmed, the use of chromato- 
graphically purified fractions of dialysate may yet prove amenable to the study 
of the relationship between the antigen-specific and nonspecific activities of TF 
preparations both  in  vitro  and in  vivo.  In  any event the adjuvant effect of 
leukocyte dialysates on populations of lymphocytes proliferating in vitro should 
be considered in interpretating both the specific and nonspecific effects of TF 
reported in the course of clinical immunotherapy (2). The relation of these in 
vitro effects of leukocyte dialysates to such specific and nonspecific effects after 
administration of TF in vivo, remains to be elucidated. 
Summary 
After our initial report that leukocyte dialysates containing transfer factor 
augment the thymidine incorporation of antigen-stimulated lymphocytes, we 
have adapted the system to microleukocyte  cultures. This modification permits 
both (a) the simultaneous assay of a  single dialysate on the cells of multiple 
individuals, and  (b) the assay of multiple dialysates on the cells of a  single 
individual. The data thus secured, demonstrate that dialysates from both skin- 
test-positive and -negative donors produced similar degrees of augmentation 
whether the data are expressed as an arithmetic difference or as a ratio. When 
expressed as an arithmetic difference, the amount of augmentation is increased 
in proportion to the level of thymidine incorporation of the assay cells when they 
were stimulated by antigen alone.  When expressed as a  ratio,  however, the 
degree of augmentation is independent of the response of the assay cells. COHEN,  HOLZMAN,  VALENTINE,  AND  LAWRENCE  803 
An  analysis  of the  ability of dialysates to engage previously uncommitted 
lymphocytes and thus to augment thymidine incorporation, revealed that pre- 
committed  cells  were  required.  In  these  experiments,  antigen-reactive cells 
were deleted from populations of peripheral blood lymphocytes by incubation 
with purified protein derivative of tuberculin, diphtheria toxoid, or streptoki- 
nase-streptodornase in the presence of [3H]thymidine of high specific activity. 
This  deletion  depressed  or  abolished  the  effect of dialysate  on  the  residual 
population when it was recultured with the same antigen, but the effect on the 
response of the remaining lymphocytes to other antigens was unaltered. 
In this study,  leukocyte dialysate appeared to augment nonspecifically the 
thymidine incorporation of an antigen-specific precommitted clone of lympho- 
cytes. The relationship of  these adjuvant effects on peripheral blood lymphocytes 
in  vitro  to  the  specific  and  nonspecific  activities  of transfer  factor  in  vivo 
remains to be elucidated. 
Received for publication 9 December 1975. 
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